Literature DB >> 28324300

α-Synuclein and Parkinsonism: Updates and Future Perspectives.

Kaie Rosborough1, Neha Patel1, Lorraine V Kalia2,3,4.   

Abstract

Mutations in the SNCA gene, which encodes the α-synuclein protein, were the first discovered genetic causes of familial parkinsonism with Lewy pathology. To date, six different SNCA missense mutations as well as multiplications are known to cause parkinsonism. For this review, we performed a literature search to identify all published cases of SNCA-related parkinsonism to provide an updated summary of the clinical and neuropathological features of parkinsonism due to SNCA mutations. Familial parkinsonism associated with SNCA is rare, but α-synuclein aggregation is a core feature of sporadic parkinsonism, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Research into α-synuclein and parkinsonism has impacted how we define the pathology and understand the pathogenesis of Parkinson's disease and related neurodegenerative disorders. We briefly discuss some of the lessons we have learned from research into the physiological role of α-synuclein and its pathological links to neurodegeneration and parkinsonism.

Entities:  

Keywords:  Dementia with Lewy bodies; Lewy pathology; Multiple system atrophy; Parkinson’s disease; Phenotype; SNCA

Mesh:

Substances:

Year:  2017        PMID: 28324300     DOI: 10.1007/s11910-017-0737-y

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  108 in total

1.  Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein.

Authors:  A Athanassiadou; G Voutsinas; L Psiouri; E Leroy; M H Polymeropoulos; A Ilias; G M Maniatis; T Papapetropoulos
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes.

Authors:  C Richter-Landsberg; M Gorath; J Q Trojanowski; V M Lee
Journal:  J Neurosci Res       Date:  2000-10-01       Impact factor: 4.164

Review 3.  Genetics of Parkinson's disease.

Authors:  Christine Klein; Ana Westenberger
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

4.  The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease.

Authors:  C-S Ki; E F Stavrou; N Davanos; W Y Lee; E J Chung; J-Y Kim; A Athanassiadou
Journal:  Clin Genet       Date:  2007-05       Impact factor: 4.438

5.  Prominent psychiatric symptoms and glucose hypometabolism in a family with a SNCA duplication.

Authors:  T Uchiyama; T Ikeuchi; Y Ouchi; M Sakamoto; K Kasuga; A Shiga; M Suzuki; M Ito; T Atsumi; T Shimizu; T Ohashi
Journal:  Neurology       Date:  2008-10-14       Impact factor: 9.910

6.  Detection of copy number changes in genes associated with Parkinson's disease in Iranian patients.

Authors:  Hossein Darvish; Abolfazl Movafagh; Mir Davood Omrani; Saghar Ghasemi Firouzabadi; Eznollah Azargashb; Javad Jamshidi; Ali Khaligh; Leyla Haghnejad; Nilofar Safavi Naeini; Atefeh Talebi; Hamid Reza Heidari-Rostami; Hamid Noorollahi-Moghaddam; Siamak Karkheiran; Gholam-Ali Shahidi; Seyed Mohammad Hassan Paknejad; Hossein Ashrafian; Siamak Abdi; Matin Kayyal; Mojdeh Akbari; Negar Pedram; Babak Emamalizadeh
Journal:  Neurosci Lett       Date:  2013-07-21       Impact factor: 3.046

Review 7.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

8.  Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.

Authors:  Takeshi Ikeuchi; Akiyoshi Kakita; Atsushi Shiga; Kensaku Kasuga; Hiryoyuki Kaneko; Chun-Feng Tan; Jiro Idezuka; Koichi Wakabayashi; Osamu Onodera; Takeshi Iwatsubo; Masatoyo Nishizawa; Hitoshi Takahashi; Atsushi Ishikawa
Journal:  Arch Neurol       Date:  2008-04

9.  Motor and Nonmotor Features of Carriers of the p.A53T Alpha-Synuclein Mutation: A Longitudinal Study.

Authors:  Dimitra Papadimitriou; Roubina Antonelou; Michael Miligkos; Matina Maniati; Nikolaos Papagiannakis; Sevasti Bostantjopoulou; Athannassios Leonardos; Christos Koros; Athina Simitsi; Sokratis G Papageorgiou; Elisabeth Kapaki; Roy N Alcalay; Alexandros Papadimitriou; Aglaia Athanassiadou; Maria Stamelou; Leonidas Stefanis
Journal:  Mov Disord       Date:  2016-03-29       Impact factor: 10.338

10.  Structural basis of synaptic vesicle assembly promoted by α-synuclein.

Authors:  Giuliana Fusco; Tillmann Pape; Amberley D Stephens; Pierre Mahou; Ana Rita Costa; Clemens F Kaminski; Gabriele S Kaminski Schierle; Michele Vendruscolo; Gianluigi Veglia; Christopher M Dobson; Alfonso De Simone
Journal:  Nat Commun       Date:  2016-09-19       Impact factor: 14.919

View more
  28 in total

1.  Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Authors:  Richard A Maki; Michael Holzer; Khatereh Motamedchaboki; Ernst Malle; Eliezer Masliah; Gunther Marsche; Wanda F Reynolds
Journal:  Free Radic Biol Med       Date:  2019-06-06       Impact factor: 7.376

2.  Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.

Authors:  Hideki Hayakawa; Rie Nakatani; Kensuke Ikenaka; Cesar Aguirre; Chi-Jing Choong; Hiroshi Tsuda; Seiichi Nagano; Masato Koike; Takeshi Ikeuchi; Masato Hasegawa; Stella M Papa; Yoshitaka Nagai; Hideki Mochizuki; Kousuke Baba
Journal:  Mov Disord       Date:  2019-10-23       Impact factor: 10.338

Review 3.  The emerging role of α-synuclein truncation in aggregation and disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

Review 4.  Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease.

Authors:  Darren M O'Hara; Suneil K Kalia; Lorraine V Kalia
Journal:  Br J Pharmacol       Date:  2018-06-03       Impact factor: 8.739

Review 5.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 6.  Lysosomal dysfunction in neurodegeneration: emerging concepts and methods.

Authors:  Vinod Udayar; Yu Chen; Ellen Sidransky; Ravi Jagasia
Journal:  Trends Neurosci       Date:  2022-01-13       Impact factor: 13.837

Review 7.  Consequences of variability in α-synuclein fibril structure on strain biology.

Authors:  Sara A M Holec; Samantha L Liu; Amanda L Woerman
Journal:  Acta Neuropathol       Date:  2022-02-04       Impact factor: 17.088

8.  Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes.

Authors:  Mechelle M Lewis; Guangwei Du; Jennifer Baccon; Amanda M Snyder; Ben Murie; Felicia Cooper; Christy Stetter; Lan Kong; Christopher Sica; Richard B Mailman; James R Connor; Xuemei Huang
Journal:  Mov Disord       Date:  2018-05-14       Impact factor: 10.338

Review 9.  A Practical Approach to Early-Onset Parkinsonism.

Authors:  Giulietta M Riboldi; Emanuele Frattini; Edoardo Monfrini; Steven J Frucht; Alessio Di Fonzo
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

10.  Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy.

Authors:  Zachary A Sorrentino; Ethan Hass; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Jess-Karan S Dhillon; Benoit I Giasson
Journal:  Neurosci Lett       Date:  2020-05-01       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.